Rural Health
Resources by Topic: Prescription drug misuse
Vermont Results First: Inventory and Benefit-Cost Analysis for the Department of Health/Division of Alcohol and Drug Abuse Program's Medication Assisted Treatment for Opioid Use Disorder (Hub and Spoke)
Examines the program inventory and benefit-cost analysis of Vermont's Care Alliance for Opioid Addiction, a "Hub and Spoke" system of regional opioid treatment programs that treat individuals with opioid use disorder using medication along with counseling and supportive services.
Date: 12/2017
Sponsoring organizations: Criminal Research Group, Results First Initiative, Justice Research and Statistics Association, State of Vermont Blueprint for Health, Vermont Department of Health, Division of Alcohol and Drug Abuse Programs (ADAP)
view details
Examines the program inventory and benefit-cost analysis of Vermont's Care Alliance for Opioid Addiction, a "Hub and Spoke" system of regional opioid treatment programs that treat individuals with opioid use disorder using medication along with counseling and supportive services.
Date: 12/2017
Sponsoring organizations: Criminal Research Group, Results First Initiative, Justice Research and Statistics Association, State of Vermont Blueprint for Health, Vermont Department of Health, Division of Alcohol and Drug Abuse Programs (ADAP)
view details
Examining Substance Use Disorder Treatment Demand and Provider Capacity in a Changing Health Care System: Final Report
Assesses demand and capacity for substance use disorder treatment, with comparisons between years 2013 and 2016. Features statistics including numbers of clients, staff hours, percentage of facilities offering pharmacotherapies and accepting various insurance types, and distribution of specialty treatments, with breakdowns by urban and rural locations.
Author(s): Ellen Bouchery
Date: 12/2017
Sponsoring organization: U.S. Department of Health and Human Services
view details
Assesses demand and capacity for substance use disorder treatment, with comparisons between years 2013 and 2016. Features statistics including numbers of clients, staff hours, percentage of facilities offering pharmacotherapies and accepting various insurance types, and distribution of specialty treatments, with breakdowns by urban and rural locations.
Author(s): Ellen Bouchery
Date: 12/2017
Sponsoring organization: U.S. Department of Health and Human Services
view details
Vermont Hub-and-Spoke Model of Care for Opioid Use Disorders: An Evaluation
Details an evaluation of Vermont's hub-and-spoke model of medication-assisted treatment (MAT) for opioid addiction. Discusses the system's successes and areas that need focus and improvement.
Additional links: Summary Brief
Author(s): Richard A. Rawson
Date: 12/2017
Sponsoring organization: Vermont Center on Behavior & Health
view details
Details an evaluation of Vermont's hub-and-spoke model of medication-assisted treatment (MAT) for opioid addiction. Discusses the system's successes and areas that need focus and improvement.
Additional links: Summary Brief
Author(s): Richard A. Rawson
Date: 12/2017
Sponsoring organization: Vermont Center on Behavior & Health
view details
Behavioral, Mental, and Physical Health Characteristics and Opioid Medication Misuse among Community Pharmacy Patients: A Latent Class Analysis
Study of opioid misuse risk factors based on mental, behavioral, and physical health characteristics for patients in 2 rural and 2 urban Pennsylvania counties. Uses latent class analysis methodology to identify combinations of indicators that may be visible to pharmacists and that may suggest increased risk of opioid misuse, including age, employment, whether a pharmacy is in a rural area, and education level.
Author(s): Gerald Cochran, Valerie Hruschak, Jennifer L. Bacci, Kenneth C. Hohmeier, Ralph Tarter
Citation: Research in Social and Administrative Pharmacy, 13(6), 1055-1061
Date: 11/2017
view details
Study of opioid misuse risk factors based on mental, behavioral, and physical health characteristics for patients in 2 rural and 2 urban Pennsylvania counties. Uses latent class analysis methodology to identify combinations of indicators that may be visible to pharmacists and that may suggest increased risk of opioid misuse, including age, employment, whether a pharmacy is in a rural area, and education level.
Author(s): Gerald Cochran, Valerie Hruschak, Jennifer L. Bacci, Kenneth C. Hohmeier, Ralph Tarter
Citation: Research in Social and Administrative Pharmacy, 13(6), 1055-1061
Date: 11/2017
view details
Pain in the Nation: The Drug, Alcohol and Suicide Crises and the Need for a National Resilience Strategy
Examines current trends, causes, costs, and potential solutions to the drug, alcohol, and suicide crises in the U.S. Includes rural data and discussion of rural-specific issues.
Author(s): Laura M. Segal, Anne De Biasi, Jennifer L. Mueller, Kendra May, Molly Warren
Date: 11/2017
Sponsoring organization: Trust for America's Health
view details
Examines current trends, causes, costs, and potential solutions to the drug, alcohol, and suicide crises in the U.S. Includes rural data and discussion of rural-specific issues.
Author(s): Laura M. Segal, Anne De Biasi, Jennifer L. Mueller, Kendra May, Molly Warren
Date: 11/2017
Sponsoring organization: Trust for America's Health
view details
The Front Lines of the Opioid Crisis: Perspectives from States, Communities, and Providers
Video recording details the Senate Health, Education, Labor, and Pensions (HELP) Committee hearing on the opioid epidemic. Features testimony detailing efforts to combat opioid addiction from representatives of the Virginia Commonwealth University School of Dentistry; the Rhode Island Department of Behavioral Healthcare, Developmental Disabilities and Hospitals; the Wisconsin Prescription Drug Monitoring Program; and the Kentucky Justice and Public Safety Cabinet.
Date: 11/2017
Sponsoring organization: Senate Committee on Health, Education, Labor & Pensions
view details
Video recording details the Senate Health, Education, Labor, and Pensions (HELP) Committee hearing on the opioid epidemic. Features testimony detailing efforts to combat opioid addiction from representatives of the Virginia Commonwealth University School of Dentistry; the Rhode Island Department of Behavioral Healthcare, Developmental Disabilities and Hospitals; the Wisconsin Prescription Drug Monitoring Program; and the Kentucky Justice and Public Safety Cabinet.
Date: 11/2017
Sponsoring organization: Senate Committee on Health, Education, Labor & Pensions
view details
Robert Pack & Maggie Elehwany: VRHA Keynoters--and VRHA Board President Summer Sage
Recording from the 2017 Virginia Rural Health Association (VRHA)'s Rural Health Providers Conference. Discussion of new rural healthcare-related education initiatives and resources, grant funding to help combat the Virginia opioid crisis, and rural health policy developments on the federal level and their impact on rural areas.
Date: 11/2017
Sponsoring organizations: Center for Rural Affairs, National Rural Education Association
view details
Recording from the 2017 Virginia Rural Health Association (VRHA)'s Rural Health Providers Conference. Discussion of new rural healthcare-related education initiatives and resources, grant funding to help combat the Virginia opioid crisis, and rural health policy developments on the federal level and their impact on rural areas.
Date: 11/2017
Sponsoring organizations: Center for Rural Affairs, National Rural Education Association
view details
The President's Commission on Combating Drug Addiction and the Opioid Crisis
Includes recommendations set forth by the Trump Administration President's Commission on Combating Drug Addiction and the Opioid Crisis to combat the opioid epidemic. Discussed plans for federal funding, prevention, treatment, education, and research, as well as the role of the Department of Health and Human Services and the Department of Justice in facilitating the proposed course of action.
Date: 11/2017
Sponsoring organization: The President's Commission on Combating Drug Addiction and the Opioid Crisis
view details
Includes recommendations set forth by the Trump Administration President's Commission on Combating Drug Addiction and the Opioid Crisis to combat the opioid epidemic. Discussed plans for federal funding, prevention, treatment, education, and research, as well as the role of the Department of Health and Human Services and the Department of Justice in facilitating the proposed course of action.
Date: 11/2017
Sponsoring organization: The President's Commission on Combating Drug Addiction and the Opioid Crisis
view details
Silence Surrounding Hepatitis C Status in Risk Relationships among Rural People Who Use Drugs
Highlights a study on hepatitis C (HCV) status among rural people who use drugs by injection (PWIDs). Discusses the rates at which HCV-positive PWIDs disclosed their diagnosis to their partners, close friends, and family.
Author(s): Megan G. Hofmeister, Jennifer R. Havens, April M. Young
Citation: The Journal of Primary Prevention, 38(5), 481-494
Date: 10/2017
view details
Highlights a study on hepatitis C (HCV) status among rural people who use drugs by injection (PWIDs). Discusses the rates at which HCV-positive PWIDs disclosed their diagnosis to their partners, close friends, and family.
Author(s): Megan G. Hofmeister, Jennifer R. Havens, April M. Young
Citation: The Journal of Primary Prevention, 38(5), 481-494
Date: 10/2017
view details
Prescription Opioid Misuse among Rural Community Pharmacy Patients: Pilot Study for Screening and Implications for Future Practice and Research
Examines rural and urban community pharmacy patients in Pennsylvania to describe and compare patterns of opioid medication misuse. Identifies demographic and risk factors associated with rural and urban opioid medication misuse. Includes demographic statistics by rural and urban areas, such as education, employment status, and misuse behaviors. Offers recommendations to address opioid medication misuse.
Author(s): Gerald T. Cochran, Rafael J. Engel, Valerie J. Hruschak, Ralph E. Tarter
Citation: Journal of Pharmacy Practice, 30(5), 498-505
Date: 10/2017
view details
Examines rural and urban community pharmacy patients in Pennsylvania to describe and compare patterns of opioid medication misuse. Identifies demographic and risk factors associated with rural and urban opioid medication misuse. Includes demographic statistics by rural and urban areas, such as education, employment status, and misuse behaviors. Offers recommendations to address opioid medication misuse.
Author(s): Gerald T. Cochran, Rafael J. Engel, Valerie J. Hruschak, Ralph E. Tarter
Citation: Journal of Pharmacy Practice, 30(5), 498-505
Date: 10/2017
view details